{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:45:35Z","timestamp":1789202735662,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Cure SMA Industry Collaboration"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40120-025-00753-7","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:23:40Z","timestamp":1746271420000},"page":"1083-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SMA Community Priorities for Future Drug Therapies: Cross-Sectional Survey Findings Representing 410 Adults with SMA"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6579-9720","authenticated-orcid":false,"given":"Ilse S.","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-8433","authenticated-orcid":false,"given":"Ramaa","family":"Chitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-4669","authenticated-orcid":false,"given":"Mary A.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8348-1916","authenticated-orcid":false,"given":"Lisa T.","family":"Belter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"1","key":"753_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, et al. Prevalence, incidence and carrier frequency of 5q\u2013linked spinal muscular atrophy \u2013 a literature review. Orphanet J Rare Dis. 2017;12(1):124.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"753_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/mus.27519","volume":"65","author":"N Rad","year":"2022","unstructured":"Rad N, Cai H, Weiss MD. Management of spinal muscular atrophy in the adult population. Muscle Nerve. 2022;65(5):498\u2013507.","journal-title":"Muscle Nerve"},{"key":"753_CR3","unstructured":"Cure SMA. Newborn screening for SMA. https:\/\/www.curesma.org\/newborn-screening-for-sma\/. Accessed 2025 Jan 21."},{"issue":"2","key":"753_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(23)00419-2","volume":"23","author":"CJJ Yeo","year":"2024","unstructured":"Yeo CJJ, Tizzano EF, Darras BT. Challenges and opportunities in spinal muscular atrophy therapeutics. Lancet Neurol. 2024;23(2):205\u201318.","journal-title":"Lancet Neurol"},{"issue":"1","key":"753_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12887-022-03671-x","volume":"22","author":"JW Day","year":"2022","unstructured":"Day JW, Howell K, Place A, et al. Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatr. 2022;22(1):632.","journal-title":"BMC Pediatr"},{"issue":"1","key":"753_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-020-1339-3","volume":"15","author":"HWY Wan","year":"2020","unstructured":"Wan HWY, Carey KA, D\u2019Silva A, et al. Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review. Orphanet J Rare Dis. 2020;15(1):70.","journal-title":"Orphanet J Rare Dis"},{"key":"753_CR7","unstructured":"Cure SMA. Voice of the patient report: spinal muscular atrophy (SMA). 2018. https:\/\/www.curesma.org\/wp-content\/uploads\/2018\/01\/SMA-VoP-for-publication-1-22-2018.pdf. Accessed 2025 Jan 21."},{"key":"753_CR8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006241","author":"P Mongiovi","year":"2018","unstructured":"Mongiovi P, Dilek N, Garland C, et al. Patient reported impact of symptoms in spinal muscular atrophy (PRISM-SMA). Neurology. 2018. https:\/\/doi.org\/10.1212\/WNL.0000000000006241.","journal-title":"Neurology"},{"key":"753_CR9","unstructured":"Cure SMA. SMA drug pipeline. https:\/\/www.curesma.org\/wp-content\/uploads\/2025\/02\/2025_Feb-Graphic-Pipeline_v3-scaled.jpg. Accessed 2025 Feb 18."},{"key":"753_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120059","volume":"432","author":"D Trundell","year":"2022","unstructured":"Trundell D, Skalicky A, Staunton H, et al. Development of the SMA independence scale\u2013upper limb module (SMAIS\u2013ULM): a novel scale for individuals with type\u00a02 and non-ambulant type\u00a03 SMA. J Neurol Sci. 2022;432:120059.","journal-title":"J Neurol Sci"},{"issue":"3","key":"753_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/mus.27785","volume":"67","author":"R Sadjadi","year":"2023","unstructured":"Sadjadi R, Kelly K, Glanzman AM, et al. Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysis. Muscle Nerve. 2023;67(3):239\u201343.","journal-title":"Muscle Nerve"},{"issue":"1","key":"753_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-200563","volume":"8","author":"L Belter","year":"2020","unstructured":"Belter L, Jarecki J, Reyna SP, et al. The cure SMA membership surveys: highlights of key demographic and clinical characteristics of individuals with spinal muscular atrophy. J Neuromuscul Dis. 2020;8(1):109\u201323.","journal-title":"J Neuromuscul Dis"},{"key":"753_CR13","unstructured":"Cure SMA. State of SMA. https:\/\/www.curesma.org\/wp-content\/uploads\/2024\/06\/9042024_State-of-SMA_vWeb.pdf. Accessed 2025 Jan 21."}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00753-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T13:58:24Z","timestamp":1747663104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00753-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00753-7","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ilse S. Peterson, Ramaa Chitale, Mary A. Curry, and Lisa T. Belter have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Institutional review board (IRB) approval was obtained by WCG IRB (IRB ID: 20173058). This study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. All subjects provided informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}